Mississippi Veterans PTSD Ibogaine Research Pilot Program; create.

SB 2562 creates the Mississippi Veterans PTSD Ibogaine Research Pilot Program within the State Department of Health to support clinical research using ibogaine for volunteer Mississippi veterans diagnosed with PTSD. The bill reclassifies ibogaine from Mississippi's Schedule I to Schedule II controlled substance for research purposes only, requiring strict research protocols, institutional review board approvals, and annual reports to the legislature. It limits participation to Mississippi-resident veterans with documented PTSD who volunteer without compensation, prohibits prescribing ibogaine outside the research, and mandates the program expire on July 1, 2028. The bill died in committee on February 3, 2026, and was never enacted.